热门资讯> 正文

AC Immune报告财年业绩

2025-03-13 19:25

AC Immune SA(ACIU) 0

AC Immune press release (NASDAQ:ACIU): FY GAAP EPS of -CHF0.51.
Revenue of CHF27.31M (+84.5% Y/Y).
Cash resources of CHF 165.5 million at year end provides funding into Q1 2027, assuming no other milestones.

More on AC Immune

AC Immune: Leader In Dementia Therapies, A Space Littered With Failures
Seeking Alpha’s Quant Rating on AC Immune
Historical earnings data for AC Immune
Financial information for AC Immune

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。